|
Volumn 51, Issue 2, 2008, Pages 251-
|
Gut microbiota: A new aspect that should be taken into more consideration when assessing the toxicity of chemicals or the adverse effects and efficacy of drugs
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ARSINE DERIVATIVE;
GINSENOSIDE RB 1;
PROTEINASE;
SACCHARIN;
ADVERSE OUTCOME;
ANTIMICROBIAL ACTIVITY;
DRUG EFFICACY;
DRUG METABOLISM;
ENTERITIS;
ENZYME INACTIVATION;
INTESTINE FLORA;
LETTER;
MICROBIAL METABOLISM;
MICROFLORA;
NONHUMAN;
PRIORITY JOURNAL;
HUMANS;
INTESTINES;
PHARMACEUTICAL PREPARATIONS;
RISK ASSESSMENT;
TOXICITY TESTS;
|
EID: 44649176941
PISSN: 02732300
EISSN: 10960295
Source Type: Journal
DOI: 10.1016/j.yrtph.2008.04.004 Document Type: Letter |
Times cited : (4)
|
References (10)
|